SOLLINI, Martina
 Distribuzione geografica
Continente #
NA - Nord America 3.349
AS - Asia 2.739
EU - Europa 893
SA - Sud America 511
AF - Africa 122
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 7.630
Nazione #
US - Stati Uniti d'America 3.262
SG - Singapore 1.630
CN - Cina 493
BR - Brasile 416
VN - Vietnam 279
FI - Finlandia 175
IE - Irlanda 136
IT - Italia 118
DE - Germania 107
IN - India 77
GB - Regno Unito 71
SE - Svezia 67
NG - Nigeria 63
HK - Hong Kong 56
FR - Francia 53
CA - Canada 51
AR - Argentina 46
NL - Olanda 38
BD - Bangladesh 27
IQ - Iraq 27
MX - Messico 24
RU - Federazione Russa 24
ES - Italia 18
PL - Polonia 17
TR - Turchia 16
ZA - Sudafrica 14
BE - Belgio 13
CL - Cile 12
JP - Giappone 12
ID - Indonesia 11
IR - Iran 11
AT - Austria 10
EC - Ecuador 10
IL - Israele 10
PK - Pakistan 10
UZ - Uzbekistan 10
CO - Colombia 9
TN - Tunisia 9
UA - Ucraina 9
EU - Europa 8
SA - Arabia Saudita 8
KG - Kirghizistan 7
LT - Lituania 7
VE - Venezuela 7
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
MA - Marocco 6
PH - Filippine 6
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
MY - Malesia 5
PE - Perù 5
AZ - Azerbaigian 4
CH - Svizzera 4
HR - Croazia 4
JM - Giamaica 4
OM - Oman 4
RO - Romania 4
SN - Senegal 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
LB - Libano 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
SY - Repubblica araba siriana 3
EE - Estonia 2
KR - Corea 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 7.630
Città #
Singapore 724
Ashburn 456
San Jose 283
Chandler 280
The Dalles 240
Wilmington 224
Shanghai 215
Helsinki 175
Dallas 157
Beijing 153
San Mateo 147
Dublin 135
Boardman 122
New York 116
Ho Chi Minh City 107
Ann Arbor 91
Benin City 63
Lawrence 60
Princeton 60
Hanoi 53
Hong Kong 50
Los Angeles 47
Pune 42
Leawood 41
London 39
Amsterdam 34
Santa Clara 34
São Paulo 33
Milan 29
Paris 28
Toronto 27
Fairfield 26
Da Nang 25
Seattle 24
Brooklyn 23
Woodbridge 22
Monmouth Junction 21
Haiphong 19
Phoenix 17
Rio de Janeiro 16
Warsaw 16
Belo Horizonte 15
Boston 13
Brussels 13
Redwood City 13
Baghdad 12
Orem 12
Falkenstein 11
Florence 11
Johannesburg 11
Naples 11
Stockholm 11
Montreal 10
Moscow 10
Munich 10
Tashkent 10
Brasília 9
Curitiba 9
Manchester 9
Norwalk 9
Porto Alegre 9
Campinas 8
Mexico City 8
Tokyo 8
Atlanta 7
Chennai 7
Kocaeli 7
San Francisco 7
Santiago 7
Zhengzhou 7
Bishkek 6
Chicago 6
Des Moines 6
Redmond 6
Reston 6
Sorocaba 6
Vienna 6
Addis Ababa 5
Biên Hòa 5
Calgary 5
Charlotte 5
Council Bluffs 5
Düsseldorf 5
Fortaleza 5
Goiânia 5
Hangzhou 5
Ipatinga 5
Munro 5
Nairobi 5
Osasco 5
Quito 5
San Diego 5
Tel Aviv 5
Amman 4
Andover 4
Baku 4
Buffalo 4
Dakar 4
Denver 4
Hải Dương 4
Totale 4.908
Nome #
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 123
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 121
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 119
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 117
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 103
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 98
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 95
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 95
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 92
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 90
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 89
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 89
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 89
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 86
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 86
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 86
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 85
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 85
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 84
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 83
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 82
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 82
PET/CT radiomics in breast cancer: Mind the step 82
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 81
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 79
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 78
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 78
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 77
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 76
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 76
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 75
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 74
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 74
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 73
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 72
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 72
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 71
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 70
Cardiac molecular pathways influenced by doxorubicin treatment in mice 69
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 68
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 68
The "3M" Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary 67
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 67
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 66
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 65
Methodological framework for radiomics applications in Hodgkin’s lymphoma 64
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 64
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 63
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 63
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 63
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 63
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 63
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. 61
18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study 61
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 60
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 60
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 59
The use of 18F-FDG-PET/CT in the diagnostic workup of CIED infections: another perspective 57
Radiomics of Liver Metastases: A Systematic Review 57
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 56
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 56
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 55
PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors 54
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 53
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 53
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 53
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results 52
[18F]FDG-PET/CT texture analysis in thyroid incidentaloma: preliminary results 52
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 52
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 51
Alternative Nuclear Imaging Tools for Infection Imaging 51
Total glycolytic volume and biological markers in mesothelioma patients 51
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome 51
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 51
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 50
PET/MRI in Infection and Inflammation 49
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 48
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 48
(18)F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer 48
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 48
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 48
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 48
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 46
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis 45
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 45
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 45
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 44
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 43
Biomarkers in well differentiated thyroid cancer 43
Nuclear Medicine Imaging of Spondylodiscitis: The Emerging Role of PET 43
Diagnostic performances of [18f]fluorocholine positron emission tomography in brain tumors 42
Combined imaging approach to diagnose a meningioma in a patient with prostate and lung cancers 42
Reply to: "Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings" 42
New approaches for imaging and therapy of solid cancer 42
Methodological Aspects of Lymphoscintigraphy: Bicompartmental Versus Monocompartmental Radiocolloid Administration 42
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact 42
Current Status of Molecular Imaging in Infections 41
Miniaturized Radiochemical Purity Testing for 99mTc-HMPAO, 99mTc-HMDP and 99mTc-Tetrofosmin 41
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer 41
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 41
Totale 6.563
Categoria #
all - tutte 51.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 0 0 0 0 56 9 59
2021/2022426 55 5 25 85 16 7 8 45 35 23 101 21
2022/20231.030 136 54 79 71 84 45 10 108 186 107 127 23
2023/20241.076 71 109 211 81 38 169 80 44 29 19 94 131
2024/20251.378 37 7 12 16 16 165 78 91 248 319 176 213
2025/20263.350 574 224 182 350 145 198 1.046 199 233 199 0 0
Totale 7.766